Catheter ablation of intramural outflow tract premature ventricular complexes: a multicentre study.


Journal

Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology
ISSN: 1532-2092
Titre abrégé: Europace
Pays: England
ID NLM: 100883649

Informations de publication

Date de publication:
19 05 2023
Historique:
received: 18 10 2022
accepted: 20 03 2023
medline: 1 6 2023
pubmed: 25 4 2023
entrez: 25 04 2023
Statut: ppublish

Résumé

Ablation of outflow tract ventricular arrhythmias may be limited by a deep intramural location of the arrhythmogenic source. This study evaluates the acute and long-term outcomes of patients undergoing ablation of intramural outflow tract premature ventricular complexes (PVCs). This multicenter series included patients with structurally normal heart or nonischemic cardiomyopathy and intramural outflow tract PVCs defined by: (a) ≥ 2 of the following criteria: (1) earliest endocardial or epicardial activation < 20ms pre-QRS; (2) Similar activation in different chambers; (3) no/transient PVC suppression with ablation at earliest endocardial/epicardial site; or (b) earliest ventricular activation recorded in a septal coronary vein. Ninety-two patients were included, with a mean PVC burden of 21.5±10.9%. Twenty-six patients had had previous ablations. All PVCs had inferior axis, with LBBB pattern in 68%. In 29 patients (32%) direct mapping of the intramural septum was performed using an insulated wire or multielectrode catheter, and in 13 of these cases the earliest activation was recorded within a septal vein. Most patients required special ablation techniques (one or more), including sequential unipolar ablation in 73%, low-ionic irrigation in 26%, bipolar ablation in 15% and ethanol ablation in 1%. Acute PVC suppression was achieved in 75% of patients. Following the procedure, the PVC burden was reduced to 5.8±8.4%. The mean follow-up was 15±14 months and 16 patients underwent a repeat ablation. Ablation of intramural PVCs is challenging; acute arrhythmia elimination is achieved in 3/4 patients, and non-conventional approaches are often necessary for success.

Identifiants

pubmed: 37096979
pii: 7141348
doi: 10.1093/europace/euad100
pmc: PMC10228610
pii:
doi:

Types de publication

Multicenter Study Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© The Author(s) 2023. Published by Oxford University Press on behalf of the European Society of Cardiology.

Déclaration de conflit d'intérêts

Conflict of interest: None declared.

Références

Circ Arrhythm Electrophysiol. 2011 Dec;4(6):889-96
pubmed: 21984361
J Cardiovasc Electrophysiol. 1996 Jun;7(6):531-6
pubmed: 8743758
Heart Rhythm. 2019 Jun;16(6):863-870
pubmed: 30576879
Circ Arrhythm Electrophysiol. 2021 Sep;14(9):e010375
pubmed: 34459210
J Am Coll Cardiol. 2019 Apr 2;73(12):1413-1425
pubmed: 30922472
Circ Arrhythm Electrophysiol. 2012 Apr;5(2):258-63
pubmed: 22407415
Europace. 2022 Apr 5;24(4):649
pubmed: 34850885
Heart Rhythm. 2022 Sep;19(9):1475-1483
pubmed: 35278700
Europace. 2022 Jul 15;24(6):1006-1014
pubmed: 35060596
Heart Rhythm. 2017 Jan;14(1):141-148
pubmed: 27664373
Circ Arrhythm Electrophysiol. 2011 Dec;4(6):882-8
pubmed: 22007036
JACC Clin Electrophysiol. 2017 Oct;3(10):1103-1110
pubmed: 29759492
Heart Rhythm. 2020 Sep;17(9):1609-1620
pubmed: 32333973
Europace. 2020 Mar 1;22(3):434-439
pubmed: 31876913
Europace. 2019 Aug 1;21(8):1143-1144
pubmed: 31075787
Circ Arrhythm Electrophysiol. 2022 May;15(5):e010020
pubmed: 35476455
Circ Arrhythm Electrophysiol. 2016 Sep;9(9):
pubmed: 27625170
Heart Rhythm. 2021 Aug;18(8):1445-1451
pubmed: 33892203
Europace. 2022 Jul 15;24(6):959-969
pubmed: 34922350
Heart Rhythm. 2020 Jul;17(7):1176-1184
pubmed: 32087355
JACC Clin Electrophysiol. 2020 Oct 26;6(11):1339-1348
pubmed: 33121661
Neth Heart J. 2018 Apr;26(4):173-174
pubmed: 29484566
Circulation. 2019 Jan 15;139(3):313-321
pubmed: 30586734
J Am Coll Cardiol. 2008 Jul 8;52(2):139-47
pubmed: 18598894

Auteurs

Matthew Hanson (M)

Division of Cardiology, Queen's University, 76 Stuart Street, Kingston, Ontario K7L 2V7, Canada.

Piotr Futyma (P)

University of Rzeszów and St. Joseph's Heart Rhythm Center, Rzeszów, Poland.

Weeranun Bode (W)

Electrophysiology Section, Division of Cardiovascular Medicine, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania, USA.

Jackson J Liang (JJ)

Division of Cardiovascular Medicine, University of Michigan, Ann Arbor, MI, USA.

Carlos Tapia (C)

Fundación Cardioinfantil, Instituto de Cardiología, Bogotá, Colombia.

Christian Adams (C)

Fundación Cardioinfantil, Instituto de Cardiología, Bogotá, Colombia.

Łukasz Zarębski (Ł)

University of Rzeszów and St. Joseph's Heart Rhythm Center, Rzeszów, Poland.

Aleksandra Wrzos (A)

University of Rzeszów and St. Joseph's Heart Rhythm Center, Rzeszów, Poland.

Luis Saenz (L)

Fundación Cardioinfantil, Instituto de Cardiología, Bogotá, Colombia.

Mouhannad Sadek (M)

Division of Cardiology, University of Ottawa Heart Institute, Ottawa, Ontario, Canada.

Daniele Muser (D)

Electrophysiology Section, Division of Cardiovascular Medicine, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania, USA.

Adrian Baranchuk (A)

Division of Cardiology, Queen's University, 76 Stuart Street, Kingston, Ontario K7L 2V7, Canada.

Francis Marchlinski (F)

Electrophysiology Section, Division of Cardiovascular Medicine, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania, USA.

Pasquale Santangeli (P)

Electrophysiology Section, Division of Cardiovascular Medicine, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania, USA.

Fermin Garcia (F)

Electrophysiology Section, Division of Cardiovascular Medicine, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania, USA.

Andres Enriquez (A)

Division of Cardiology, Queen's University, 76 Stuart Street, Kingston, Ontario K7L 2V7, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH